Doron Therapeutics
PrivateLast Round
Series A
Nov 25, 2024
Total Funding Raised
$11M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Doron Therapeutics operates in Healthcare & Life Sciences and is based in Chapel Hill, North Carolina. Its latest recorded funding round was a Series A round in November 2024.
Doron Therapeutics is a clinical-stage biotechnology company developing biologic therapies for osteoarthritis. The company's lead product, MOTYS™, is a Phase 3-ready intra-articular biologic drug derived from placental tissue designed to treat knee osteoarthritis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Doron Therapeutics Comparables
Compare Doron Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Genascence Corporation | 83% | |
| 4Moving Biotech | 82% | |
| Levicept | 81% |
For institutional investors. Book with your work email.
Doron Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Doron Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIM Global Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 174% MoM.
- Oct 16, 2025
Doron Therapeutics, a clinical-stage biotechnology company, is developing novel biologics for musculoskeletal diseases.
For institutional investors. Book with your work email.
Doron Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Doron Therapeutics's valuation, stock price, and market status.
Is Doron Therapeutics a public or private company?
Doron Therapeutics is a private company.
What is the current stock price of Doron Therapeutics?
Doron Therapeutics is a private company, so its shares have no public market price. Caplight tracks Doron Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Doron Therapeutics worth (valuation)?
Valuation information for Doron Therapeutics is not publicly available.
Can I buy Doron Therapeutics stock?
Doron Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Doron Therapeutics's last funding round?
Doron Therapeutics's most recent funding round was Series A on November 25, 2024.
Who are the main investors in Doron Therapeutics?
Key investors in Doron Therapeutics include SPRIM Global Investments.
Will Doron Therapeutics IPO soon?
No public IPO plans have been announced for Doron Therapeutics.
How can I track Doron Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Doron Therapeutics's shares on secondary markets.